Barbalho S, Leme Boaro B, da Silva Camarinha Oliveira J, Patocka J, Lamas C, Tanaka M
Pharmaceuticals (Basel). 2025; 18(1).
PMID: 39861194
PMC: 11768729.
DOI: 10.3390/ph18010133.
Zuo X, Zhao X, Zhang X, Li Q, Jiang X, Huang S
Breast Cancer Res. 2024; 26(1):155.
PMID: 39506852
PMC: 11542355.
DOI: 10.1186/s13058-024-01910-w.
Tian B, Zhang L, Zheng J, Kang X
Heliyon. 2024; 10(17):e37191.
PMID: 39319133
PMC: 11419907.
DOI: 10.1016/j.heliyon.2024.e37191.
Eigemann J, Janda A, Schuetz C, Lee-Kirsch M, Schulz A, Hoenig M
J Clin Immunol. 2024; 45(1):1.
PMID: 39264518
PMC: 11393190.
DOI: 10.1007/s10875-024-01799-2.
Liu M, Du Y, Gao D
Front Pharmacol. 2024; 15:1453426.
PMID: 39188947
PMC: 11345200.
DOI: 10.3389/fphar.2024.1453426.
Examining NF-κB genomic interactions by ChIP-seq and CUT&Tag.
Daly A, Schiffman A, Hoffmann A, Smale S
bioRxiv. 2024; .
PMID: 39185161
PMC: 11343132.
DOI: 10.1101/2024.08.11.607521.
NF-κB role on tumor proliferation, migration, invasion and immune escape.
Khan A, Zhang Y, Ma N, Shi J, Hou Y
Cancer Gene Ther. 2024; 31(11):1599-1610.
PMID: 39033218
DOI: 10.1038/s41417-024-00811-6.
: NF-κB Inhibition as an Alternative to Overcome Osteosarcoma Heterogeneity.
Medeiros M, Guenka S, Bastos D, Oliveira K, Brassesco M
Pharmaceuticals (Basel). 2024; 17(6).
PMID: 38931401
PMC: 11206879.
DOI: 10.3390/ph17060734.
O-GlcNAcylation in ischemic diseases.
Shi R, He T, Lin M, Xu J, Gu J, Xu H
Front Pharmacol. 2024; 15:1377235.
PMID: 38783961
PMC: 11113977.
DOI: 10.3389/fphar.2024.1377235.
The NF-κB/NUAK2 signaling axis regulates pancreatic cancer progression by targeting SMAD2/3.
Wang R, Su D, Liu Y, Huang H, Qiu J, Cao Z
iScience. 2024; 27(4):109406.
PMID: 38510132
PMC: 10951638.
DOI: 10.1016/j.isci.2024.109406.
Anabolic Steroids Activate the NF-κB Pathway in Porcine Ovarian Putative Stem Cells Independently of the ZIP-9 Receptor.
Wartalski K, Wiater J, Maciak P, Pastula A, Lis G, Samiec M
Int J Mol Sci. 2024; 25(5).
PMID: 38474077
PMC: 10932267.
DOI: 10.3390/ijms25052833.
NF-κB in biology and targeted therapy: new insights and translational implications.
Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M
Signal Transduct Target Ther. 2024; 9(1):53.
PMID: 38433280
PMC: 10910037.
DOI: 10.1038/s41392-024-01757-9.
Spotlight on HOX cluster‑embedded antisense lncRNAs in cardiovascular diseases (Review).
Zhou Y, Wu Q
Int J Mol Med. 2023; 52(6).
PMID: 37830159
PMC: 10599348.
DOI: 10.3892/ijmm.2023.5317.
Alternations of NF-κB Signaling by Natural Compounds in Muscle-Derived Cancers.
Radzka J, Lapinska Z, Szwedowicz U, Gajewska-Naryniecka A, Gizak A, Kulbacka J
Int J Mol Sci. 2023; 24(15).
PMID: 37569275
PMC: 10418583.
DOI: 10.3390/ijms241511900.
NF-kB's contribution to B cell fate decisions.
Guldenpfennig C, Teixeiro E, Daniels M
Front Immunol. 2023; 14:1214095.
PMID: 37533858
PMC: 10391175.
DOI: 10.3389/fimmu.2023.1214095.
Transcriptomic analysis reveals the regulatory mechanism underlying the indirubin-mediated amelioration of dextran sulfate sodium-induced colitis in mice.
Liu Z, Zhang J, Huang Y, Li X, Zhu H, Yang R
Pharm Biol. 2023; 61(1):1082-1093.
PMID: 37439220
PMC: 10348027.
DOI: 10.1080/13880209.2023.2233565.
Lost and Found: The Family of NF-κB Inhibitors Is Larger than Assumed in Salmonid Fish.
van Muilekom D, Collet B, Rebl H, Zlatina K, Sarais F, Goldammer T
Int J Mol Sci. 2023; 24(12).
PMID: 37373375
PMC: 10299181.
DOI: 10.3390/ijms241210229.
Methyl-Thiol-Bridged Oxadiazole and Triazole Heterocycles as Inhibitors of NF-κB in Chronic Myelogenous Leukemia Cells.
Basappa B, Jung Y, Ravish A, Xi Z, Swamynayaka A, Madegowda M
Biomedicines. 2023; 11(6).
PMID: 37371757
PMC: 10296415.
DOI: 10.3390/biomedicines11061662.
Mutations in the Vicinity of the IRAK3 Guanylate Cyclase Center Impact Its Subcellular Localization and Ability to Modulate Inflammatory Signaling in Immortalized Cell Lines.
Turek I, Nguyen T, Galea C, Abad I, Freihat L, Manallack D
Int J Mol Sci. 2023; 24(10).
PMID: 37239919
PMC: 10217915.
DOI: 10.3390/ijms24108572.
Radiation-induced bystander effect and its clinical implications.
Tang H, Cai L, He X, Niu Z, Huang H, Hu W
Front Oncol. 2023; 13:1124412.
PMID: 37091174
PMC: 10113613.
DOI: 10.3389/fonc.2023.1124412.